Why Are We Still Giving People Covid–19 Vaccines?

12th March 2021

Recently, Austria, Denmark, Norway, Iceland, Estonia, Latvia, Lithuania, Luxembourg, Romania and Italy put a hold on their roll out of the AstraZeneca COVID-19 vaccine, AZD1222.

In the case of Italy, this followed the deaths of 43-year-old soldier Stefan Patern and 50-year-old Sardinian police officer, David Villa.

Both men were taken ill and died within 48 hrs of receiving the vaccine. This added to the growing tally in Italy of people who have died shortly after vaccination. Neither man was known to have any underlying health conditions.

Austria, Estonia, Latvia, Luxembourg and Lithuania temporarily halted the roll out of one specific batch of the Astrazeneca’s vaccine following concerns raised about potential blood clotting problems.

Austria suspended their roll out following the death of a 49-year-old nurse, and severe health complications apparently induced in a 35-year-old woman who suffered a pulmonary embolism after vaccination with AZD1222.

Denmark, Norway and Iceland temporarily suspended all AstraZeneca vaccines, pending investigation. Soren Brostrom Director General of the Danish Health Authority, said:

There is extensive documentation that the vaccine is both safe and effective. But both we and the Danish health agency need to act on information about possible serious side effects, both in Denmark and in other European countries.

Meanwhile, in the UK, Dr Phil Brian, safety lead for the Medicines and Healthcare products Regulatory Agency (MHRA), urged people to continue with their vaccinations:

Vaccine safety is of paramount importance…it has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca….People should still go and get their COVID-19 vaccine when asked to do so.

This approach seems to be at odds with the precautionary principle. Other European countries have suspended their use of the vaccine precisely because they don’t know if there is a link between the vaccines and the deaths. The correlation is the reason for caution, yet the MHRA are suggesting that caution need not be applied.

It is hard to understand this rationale. There are no completed clinical trials for any of the vaccines currently being administered across the UK and mainland Europe.

Pfizer’s phase III trial won’t be completed until January 2023 and AstraZeneca’s will be complete in February 2023.

While the MHRA highlight that the link between the blood clotting problems and the vaccines has not been confirmed, the safety and efficacy of the vaccines have not been confirmed either. The MHRA makes no mention of this.

The MHRA’s most recent adverse events report notes that more than 500 people have died shortly after receiving COVID-19 vaccines:

The MHRA has received 227 UK reports of suspected ADRs to the Pfizer/BioNTech vaccine in which the patient died shortly after vaccination, 275 reports for the Oxford University/AstraZeneca vaccine and 4 where the brand of vaccine was unspecified. The majority of these reports were in elderly people or people with underlying illness. Usage of the AstraZeneca has increased rapidly and as such, so has reporting of fatal events with a temporal association with vaccination however, this does not indicate a link between vaccination and the fatalities reported. At the time of this report, nearly 125,000 people across the UK have died within 28 days of a positive test for coronavirus.

This statement is concerning. The MHRA seems to be claiming that if a person dies shortly after receiving a COVID-19 vaccine this does not indicate that there is any link to the vaccine.

This is simply wrong. If someone dies shortly following the administration of a drug then it does indicate that the drug may have been the cause, even if it does not prove it.

The MHRA and UK government appear to want it both ways here: a death following vaccination, no matter the cause, is not vaccine related, yet a death following a positive SARS-CoV-2 PCR test result, no matter the cause, is definitively a COVID-19 death. In neither case is there a determination to investigate.

The MHRA is also eager to highlight that those who have died following the vaccine were elderly people or people with underlying illness. Clearly they consider this another reason not to consider any vaccine injury possible.

According to the Office of National Statistics (ONS), of the approximate 125,000 deaths attributed COVID-19 in the UK around 113,000 were over the age of 65.

Of these, approximately 19,000 were aged between 65 -74, around 40,000 deaths were among those aged 75 – 84 and the remaining 54,000 were aged over 85.

Up until October 2020, the average age of a COVID-19 death in the UK was 82.4 years. This was slightly older than the average age of mortality from all other causes which was 81.5 years.

In December 2020, the ONS responded to a freedom of information request seeking further information on comorbidity associated with COVID-19 mortality. They stated that up until June 2020 only 8.9% of COVID-19 deaths had no other underlying illness. The remaining 91.1% had at least 1 other underlying illness, with an average of 2.3 comorbidities per decedent recorded during March and April 2020. However, the ONS added:

This publication has now been paused. Therefore, in order to provide an update of this information, we would need to create bespoke analysis … We therefore consider this to be information not held.

It appears every effort has been made to maximise reported COVID-19 mortality while minimising, or even denying, any vaccine related mortality.

Read More – Why Are We Still Giving People Covid–19 Vaccines?